Group items tagged

The UK Commission on Pharmacy Professional Leadership set up by the Chief Pharmaceutical Officers of England, Northern Ireland, Scotland and Wales has published its recommendations for the 'future of pharmacy professional leadership in the UK' on Monday (6 February). The Commission is co-chaired by Nigel Clarke, Former Chair of the General Pharmaceutical Council, and Professor Dame Jane Dacre, Professor of Medical Education at University College London Medical School. The Commission proposes that closer collaboration between professional leadership bodies and specialist professional groups as part of a Pharmacy Leadership Council will enable and support pharmacists and pharmacy technicians to meet the opportunities and challenges ahead. The Council will be set up in 2023 to lead the implementation of the report's vision and recommendations over five years. Commission Co-Chairs, Professor Dame Jane Dacre and Nigel Clarke: "The Commission has set out a collaborative approach to transform pharmacy professional leadership and deliver sustained benefits for patients and the public and pharmacy professionals in the UK.

Nursing has always been about more than just patient care. While the hands-on care nurses provide is essential, their ability to make quick decisions, solve problems, and lead teams is equally important. As nurses progress in their careers, many find themselves naturally stepping into leadership roles. These roles bring new responsibilities, from managing teams to making decisions that affect entire departments. Transitioning into leadership, though, is not always easy. It requires a different set of skills and knowledge beyond what most nurses learn in their initial training. But if you're ready to embrace the challenges, becoming a nurse leader can be an incredibly rewarding career path. Understanding the Role of a Nurse Leader A nurse leader's role goes beyond simply managing others. It involves driving improvements in patient care, advocating for better practices, and ensuring the smooth operation of healthcare settings. Leadership in nursing isn't limited to holding formal titles like "charge nurse" or "nurse manager." Even those without leadership titles can step into leadership positions by influencing change, guiding colleagues, and working toward better patient outcomes.

The Pharmacists' Defence Association (PDA) has urged its member - employed pharmacists and locum pharmacists to share their view on UK Commission on Pharmacy Professional Leadership report. The four government Chief Pharmacists have published their commission's proposal for how pharmacy leadership may develop in the UK. The association 'strongly' believes that just as it was the members of the profession that established their previous pharmacist professional leadership bodies, so it is for pharmacists to determine if they agree with these proposals and to decide what arrangements they want in future. "As an organisation that has exclusively in its membership the employed and locum pharmacists in the UK, the PDA wants to ensure that it can reflect the views of frontline pharmacists in any future discussions and decisions that could impact upon their careers. Pharmacists are encouraged to read the report, to consider its content and then ensure they respond to the forthcoming communication from the PDA." The commission report says that existing leadership bodies have "relatively low levels of membership" but does not provide details. It has also stated that it has received submissions to its consultation from many pharmacy organisations.

Today I'm proud to share with you the statement we submitted to the UK Commission on Pharmacy Professional Leadership in which we set out what professional leadership means to RPS. I recognise we haven't always been clear in communicating our ideas to members and our external stakeholders. Through the Commission, and our own Independent Review of member participation and communications, we are determined to remedy this. We're committed to lead pharmacy in the best interest of patients and the professions. This means that sometimes we will need to take difficult decisions. We will do the right thing for the long term, ultimately driving what's best for patient care. There are some key changes we believe are necessary to fulfil the profession's ambitions. To achieve a more unified approach to pharmacy leadership, we believe both pharmacists and pharmacy technicians should be represented by RPS within professional faculties that capitalise on the strengths of each discipline whilst retaining distinct professional voices. Many of our members work with pharmacy technicians every day and know just how essential they are to their role and to patient care. We feel the same at RPS and it makes perfect sense to evolve into an organisation where both professions can advance their scope of practice, working in alignment as part of the wider multi-professional team. We will develop and implement post-registration curricula and credentialing for all pharmacists and pharmacy technicians working with patients and the public. To do this we will require formal delegation of authority by the GPhC.

The Royal Pharmaceutical Society has stated that the UK Commission on Pharmacy Professional Leadership lacks the essential transparency, efficiency, and diligence needed for success, urging a shift in its approach. The Commission's operational approach hinders its ability to meet the expectations of both the profession and the public, while prioritising government interests over their needs and preferences, RPS Chief Executive Paul Bennett (R) and President Claire Anderson have jointly said. In a blog post on September 7, the RPS leaders asserted that the Commission lacks transparency and is progressing slowly in implementing proposals that were published seven months ago. "Most pharmacy leaders are growing frustrated and increasingly impatient with the Commission's perceived lack of "meaningful progress" in enhancing leadership within the field," the pair noted. In June 2022, the four UK Chief Pharmaceutical Officers (CPhOs) formed an independent Commission with leadership expertise drawn from various domains, both within and outside of pharmacy, to assess the future of professional leadership. The Pharmacy Minister Neil O'Brien recently revealed that the Commission's costs, funded by the offices of the CPhOs, amounted to £87,745.

Women accounted for 62 per cent of GPhC registrants in 2019, according to the Royal Pharmaceutical Society. Despite representing the majority of pharmacists in the UK, only 2 per cent of women are pharmacy business owners compared with 13 per cent of men. Also, the majority of senior pharmacy leadership positions are held by men, with research showing that only 36 per cent of senior pharmacy leaders are women. Sobha Sharma Kandel, superintendent pharmacist and co-owner of Neem Tree Pharmacy, Abbey Wood, London, quoted these statistics while shedding light on the representation of female leaders in the field of pharmacy. So, what is stopping women from reaching leadership positions in the profession? According to Sobha, the barriers hindering female pharmacists from attaining leadership positions include: Gender Bias and Stereotypes Lack of Representation and Role Models Glass Ceiling and Double Standards Work-Life Balance Challenges Imposter Syndrome Unequal Access to Opportunities Negotiation and Advocacy Challenges "There also continue to be gender and ethnicity pay gaps affecting women in pharmacy," said Sobha, who has been advocating for women in pharmacy by being a part of the Female Pharmacy Leaders Network.

At last Friday's Clinical Congress Conference, the NHSE Chief Pharmaceutical Officer for England at NHS England, David Webb, announced the upcoming launch of the Pharmacy Stakeholder Forum- an initiative led by NHS England aimed to improve pharmacy professional leadership and foster collaboration within the sector. Webb highlighted the forum's significance as a platform for driving transformative change in pharmacy leadership. "The aim is to deliver collaboration to develop a stronger and more united voice for pharmacy professionals," Webb emphasised. Highlighting the need to drive transformative change in pharmacy leadership, he underscored that "the overarching goal is to address key challenges facing the pharmacy profession and chart a course for future development and innovation." Scheduled to commence in June, the Pharmacy Stakeholder Forum will provide a space for diverse organisations and networks with a vested interest in pharmacy professional leadership to converge.

The Chief Pharmacist for England and Co-Chairs of professional leadership commission has responded to the questions raised by the Pharmacists Defence Association (PDA)'s member on the professional leadership survey. In early September, the PDA wrote to the UK's Chief Pharmaceutical Officers to increase transparency and confidence in the process by asking for clarification of some of the commission's thinking, assumptions, and scope. On behalf of all four CPhOs, Chief Pharmacist for England David Webb provided feedback: "The Commission has two independent co-chairs and members have agreed to abide by the 7 principles for the conduct of public life as recommended by the Nolan Commission which form part of the Terms of Reference. Commission members have been appointed on behalf of all pharmacy professionals to contribute their expertise in and knowledge of professional leadership and are not appointed to represent their particular countries, organisations, sectors or roles."

Professor Mahendra Patel OBE, CEO of the Oxford University Centre for Research Equity (CfRE), has been appointed as an independent expert member of the UK Pharmacy Professional Leadership Advisory Board. The newly established Board comprises nine independent expert members (IEMs) with outstanding leadership capabilities, who were appointed through open recruitment, ensuring a "broad, balanced, and diverse" representation. Sir Hugh Taylor KCB, the Independent Chair of the Board, and the UK Chief Pharmaceutical Officers (CPhOs) - Andrew Evans (Wales), Cathy Harrison (Northern Ireland), Alison Strath (Scotland), and David Webb (England) - announced the appointment of IEMs in an open letter to the UK pharmacy professions. "Bringing a wealth of experience and expertise, they will play a pivotal role in the Board's work to deliver an exciting vision through supporting a new and dynamic phase of collaboration," the CPhOs said. As the CEO of CfRE, Professor Patel spearheads efforts aimed at addressing inequalities in healthcare.

Rachna Chhatralia, the superintendent pharmacist at Day Lewis and winner of the 2024 Pharmacy Business Aspiring Pharmacy Leader of the Year award, points out that, despite the pharmacy workforce being predominantly female at grass roots, leadership positions in the sector are still largely dominated by males-a reality she believes "stands to benefit greatly from change." For Rachna, more women in leadership can drive meaningful advancements across the profession, bringing new perspectives and empathetic understanding that would benefit both teams and patient care. She urges women to embrace their potential, overcome doubts, and step into leadership roles, even if it means pushing themselves out of their comfort zone. However, Rachna acknowledges the distinct challenges that women face when progressing their careers, especially when balancing roles after career breaks for childcare. Having faced these obstacles herself, Rachna advises, "Women should not feel following motherhood, they cannot strive to achieve career aspirations. It may take a little longer, but it is absolutely possible." Her own career was shaped by resilience, often pushing past her doubts by focusing on the end goal. She recalls, "There were times I thought, 'I am not sure if I can do this, but I chose to challenge myself and proceed regardless.'

The General Pharmaceutical Council is appointing a new Chief Pharmacy Officer to strengthen the professional voice within the senior leadership team. This introduction is aimed at fostering a culture of enterprise leadership, inclusion and collaboration within the organisation, GPhC said in a statement. According to GPhC, the Chief Pharmacy Officer will serve as the authoritative representative of the pharmacy regulator in public, within the pharmacy professions, and increasingly in multi-disciplinary teams and collaborative regulatory work. "They will act as the executive lead on pharmacy inspection and regulatory insight, providing professional leadership within the GPhC and collaborating closely with pharmacist and pharmacy technician colleagues across the organisation." The Chief Pharmacy Officer, reporting to the Chief Executive and Registrar, will hold the highest professional position within the GPhC executive, providing pharmacy leadership across the organisation, GPhC said.

The Pharmacists' Defence Association (PDA) has submitted a 17-page contribution to the commission on the future of pharmacy professional leadership and encourages pharmacists to engage in the overall discussion. The association wants to ensure that the voice of its members is heard in the discussions about the future of professional leadership, which has been initiated by the four government Chief Pharmaceutical Officers. The PDA has published its first formal contribution to the commission, in its response it raised concern on the current exercise is being rushed and a call for the review to be conducted in a more sensible timeframe, one which enables the engagement of the whole profession. It has urged on being supportive of the creation of a Royal College of Pharmacists to take custodianship of the training and education for pharmacists and to set the requisite standards, whilst still relying upon the profession's regulators to undertake the accreditation role.

Former health secretary Sajid Javid on Tuesday (July 12) dropped out of the leadership contest to replace Boris Johnson as leader of the Conservative Party and prime minister. "There is an abundance of both ideas and talent in our party. One of the candidates will be given the honour of becoming prime minister," Javid said in a statement. "I look forward to seeing the debate unfold and to see colleagues working together as a united Conservative Party once the leadership election is concluded." Javid and chancellor of the exchequer Rishi Sunak resigned on July 5.

In a bid to bolster professional leadership within the pharmacy sector, the four government Chief Pharmaceutical Officers (CPhOs) have embarked on a significant initiative, forming the UK Pharmacy Professional Leadership Advisory Board (UKPPLAB). In a recent communication, all pharmacists and pharmacy technicians received confirmation of the board members selected by the CPhOs, alongside a note from the board's appointed chair, who was chosen collectively by the four CPhOs and reports directly to the CPhO for England. Over three years, the 21-member Board will implement recommendations from the UK Commission on Pharmacy Professional Leadership's report aimed to enhance professional fulfillment among pharmacists while simultaneously augmenting patient safety standards. This announcement also follows with the appointment of Sir Hugh Taylor as its Independent Chair and the appointment of Independent Expert Members who expressed his delight over the role's "potential to lead and support collaboration across the professions in the UK". However, the move has been met with cautious optimism from the Pharmacists' Defence Association (PDA), urging the new board to uphold transparency and openness to garner trust among pharmacists.

"Only around half of ICSs have a Chief Pharmacist," indicating a significant gap in leadership that hampers the pharmacy sector's ability to influence critical healthcare decision, a report on medicine optimisation by the Public Policy Projects (PPP) highlights. In PPP's latest report, a notable concern highlighted is the inadequate representation of pharmacy leadership within Integrated Care Systems (ICSs) despite the role of pharmacy being "central in the delivery of system priorities, with pivotal roles in improving population health and tackling inequalities". In recent years, the role of pharmacy within the NHS has evolved significantly with recent developments including Pharmacy First Services and legislative amendments that allows pharmacy technicians under PGDs to administer and supply medicines.

The Royal Pharmaceutical Society (RPS) has confirmed it will respond to UK Commission's 'call for evidence' on pharmacy professional leadership. The commission wants to ensure the professions are well equipped, with a voice to help shape the future, and enabled to develop through sharing and learning from best practice. The UK Commission on Pharmacy Professional Leadership has been set up by the chief pharmaceutical officers of England, Scotland, Wales and Northern Ireland. It will produce recommendations for the future of pharmacy professional leadership in the UK. The commission is co-chaired by Nigel Clarke, former chair of the General Pharmaceutical Council, and Professor Dame Jane Dacre, professor of medical education at University College London's Medical School. The commission will be hosting a webinar and has urged the associations and individuals to take part in 'call for evidence' which has been launched to inform and develop its work. A webinar in England will take place on Wednesday 7 September 6:30 - 8 pm. In Scotland it will be organised on Tuesday 6 September 7-8:30 pm and in Wales it will be hosted on Thursday 8 September 7-8:30 pm.

Working towards its five-year strategy, the Royal Pharmaceutical Society (RPS) has put some plan in place to change its existing structure at the executive level, which could potentially render some senior positions redundant. Though the process is in nascent stage, "two roles have been identified at potential risk of redundancy," RPS said in a statement on Thursday (March 3) afternoon, adding: "This is very much at proposal stage and no final decisions or outcomes have been reached."0 It didn't specify which two roles were going to be axed, saying: "We are unable to go into the specifics of the process for individuals due to its confidential nature, but we will of course go through a fair, reasonable and confidential consultation process and are supporting the individuals involved. "No one should be in any doubt that our commitment to education and the profession's development remains the highest priority for us, and equally support for our members, thought leadership and advocacy are core to what we do as a professional leadership body."

Boehringer Ingelheim UK & Ireland has appointed Vani Manja as its new Country Managing Director and Head of Human Pharma. Manja has been associated with Boehringer Ingelheim for over 11 years, in successful leadership roles in Germany, the United States and most recently as General Manager, India. Her career started as a commissioned officer in the Indian Army Ordnance Corps which preceded leadership roles at Becton Dickinson and McKinsey. She brings extensive experience of strategy, marketing, sales, business development, people management, and cultural transformation and is passionate about tackling healthcare inequalities and advancing sustainable healthcare. Commenting on her new role, Manja said: "It is with great heart that I bring the spirit of conscious leadership to my new role. I look forward to being fully present and partnering with key stakeholders in the healthcare ecosystem in our collective quest to improve health for humans and animals in the UK and Ireland."

In September, the Royal Pharmaceutical Society (RPS), the professional leadership body for pharmacists and pharmaceutical scientists in Great Britain, announced its proposal to transition into a Royal College. This significant step, which came following an 18-month independent review of the RPS constitution and governance, aims to strengthen the RPS's leadership role, with the ultimate goal of delivering greater benefits to patients and the public. In an exclusive interview with Pharmacy Business, Tase Oputu, chair of the RPS English Pharmacy Board, discusses the key reasons behind the proposed changes, the potential impact on pharmacists and patients, and her personal journey as the first Black Chair of the RPS Board. Benefits for pharmacists and patients When asked how this transition would benefit pharmacists and patients, Tase says, "I'm excited about RPS' proposals for change. In my view, becoming a Royal College would elevate the status of the profession and strengthen our ability to raise the profile of pharmacy, advocate for change and advance the safe and effective use of medicines for the benefit of patients and the public."

The UK Health Security Agency (UKHSA) is set for two major leadership transitions, four years after its establishment. Dame Jenny Harries has announced she will step down as UKHSA chief executive in early summer. Meanwhile, UKHSA's chief scientific officer, Professor Isabel Oliver, has been appointed chief medical officer for Wales, succeeding Sir Frank Atherton following his retirement. Appointed in April 2021 as UKHSA's first chief executive, Dame Jenny played a pivotal role in creating the agency during the COVID-19 pandemic. Under her leadership, UKHSA developed specialist scientific, data, and operational expertise to safeguard the public from infectious diseases and other health threats. Reflecting on her tenure, Dame Jenny expressed immense pride in UKHSA's early achievements.